Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B. Coutts, Robert Simister, Kenneth Butcher et al.|The Lancet|2024Cited by 134
Assessment of Discrepancies Between Follow-up Infarct Volume and 90-Day Outcomes Among Patients With Ischemic Stroke Who Received Endovascular TherapyAravind Ganesh, Piyush Ojha, Johanna M. Ospel et al.|JAMA Network Open|2021Cited by 42
Mediation of Age and Thrombectomy Outcome by Neuroimaging Markers of Frailty in Patients With StrokeFaysal Benali, Martha Marko, Nishita Singh et al.|JAMA Network Open|2024Cited by 34
Impact of Brain Frailty on Clinical Presentation and Neurologic Recovery in Acute Ischemic Stroke Patients Undergoing ThrombectomyJoachim Fladt, Faysal Benali, Tanaporn Jaroenngarmsamer et al.|Neurology|2025Cited by 12
Sex Differences in Outcomes After Tenecteplase for Minor Stroke: A Subanalysis of the TEMPO‐2 TrialAmy Yu, Andrew Micielli, Shabnam Vatanpour et al.|Journal of the American Heart Association|2025Cited by 1